"FDA-authorized migraine glasses" The authorization is narrower than the headline suggests.

“FDA-authorized migraine glasses” is likely to be a headline this week. But the authorization is narrower than that headline suggests.On August 21, the FDA granted De Novo marketing authorization to Avulux, an over-the-counter precision-filter lens intended to decrease the impact of light sensitivity in patients age 12 and older with diagnosed episodic migraine. The lenses selectively attenuate portions of the blue and amber/red spectrum around 480 and 590 nm and can be made with or without a vision prescription. #migraine #neurology #headachemedicine

FDA De Novo: DEN250026

Next
Next

Four Days. Two FDA Clearances. One Inflection Point for Alzheimer’s Diagnosis.